Main Article Content


tuberculosis was once one of the most common in low- and middle-income countries due to its high death toll (up to 1.5 million per year) among infected individuals. According to the World Health Organization's national tuberculosis control program, Iraq is a high-burden country with an annual death rate from TB of over 3000. This places Iraq at number 17 out of 22 countries in the eastern Mediterranean region. The most common issue with tuberculosis treatment is a relapse after initial treatment has been completed. The World Health Organization (WHO) defines "default" as two months or more without treatment, a correlation between defaulting status and demographic factors such as age, family income, smoking, anti-tuberculosis medicine side effects, and chronic conditions,covd19 pandemic, so The World Health Organization's DOTS strategy must be put into place with the help of all relevant organizations.

91 TB patients who live in Baghdad city involved in this study,41 of them are defaulters.

The other TB non defaulter patients ,a comparison between both group to estimate the effect of different variables on default TB treatment.

The results of this study show a correlation between defaulting status and demographic factors such as age, family income, smoking, anti-tuberculosis medicine side effects, and chronic conditions. There was no correlation between default state and variables like gender, location,.

Conclusion:- The World Health Organization's DOTS strategy must be put into place with the help of all relevant organizations, both private and public. Raise health education, help patients stay on their treatment.


TB defaulters Baghdad city Variables

Article Details

How to Cite
Abd Alhamza Obed , F. (2023). Impact of Covid19 and Different Variables on Default from Tuberculosis Treatment. Central Asian Journal of Medical and Natural Science, 4(3), 229-236.


  1. 1. World Health Organization Global tuberculosis report 2021. World Health Organization; 2021.
  2. 2. Al-Orainey I, Alhedaithy MA, Alanazi AR, Barry MA, Almajid FM. Tuberculosis incidence trends in Saudi Arabia over 20 years: 1991–2010. Ann Thorac Med 2013; 8 (3): 148– 52.
  3. 3. Moosazadeh M, Khanjani N, Nasehi M, Bahrampour A. Predicting the Incidence of Smear Positive Tuberculosis Cases in Iran Using Time Series Analysis. Iran J Public Health. 2015 Nov;44(11):1526-34.
  4. 4. World Health Organization (2010) Global tuberculosis control: WHO report 2010. WHO/HTM/TB/2010.7.
  5. 5. Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW, Cobelens FG. National survey of tuberculosis prevalence in Viet Nam.Bull World Health Organ 2010; 88 (4): 273– 80.
  6. 6. Tupasi TE, Radhakrishna S, Rivera AB, Pascual ML, Quelapio MI, et al. (1999) The 1997 Nationwide Tuberculosis Prevalence Survey in the Philippines. Int J Tuberc Lung Dis 3 (6) 471–477.
  7. 7. MOH. Overview of National Tuberculosis Control program. NTP -Iraq.Iraq-Ministry of Health ; 2014.
  8. 8. Mahler H. The tuberculosis programme in the developing countries. Bull Int Un Tuberc. 1966;37:77–82. [Google Scholar]
  9. 9. Raviglione MC, Pio A. Evolution of WHO policies for TB control, 1948-2001. Lancet. 2002;359:775–8. doi: 10.1016/S0140-6736(02)07880-7. [PubMed] [CrossRef] [Google Scholar]
  10. 10. Uplekar M, Raviglione MC. The"vertical-horizantal" debates:Bull World Health Organ.2007.
  11. 11. report of the Secretary-General. [accessed on January 27, 2021]. Available from: . [Ref list]
  12. 12. World Health Organization. Global tuberculosis report. 2020. [accessed on January 27, 2021]. Available from: .
  13. 13. Khan MS, Rego S, Rajal JB, Bond V, Fatima RK, Isani AK, et al. Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries. medRxiv. 2020 doi: [PMC free article] [PubMed] [Google Scholar]
  14. 14. India Spend. COVID-19 disrupted India's routine health services. [accessed on January 27, 2020]. Available from:
  15. 15. Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Sara Raju R. COVID-19 -Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020;67:S155–62. [PMC free article] [PubMed] [Google Scholar]
  16. 16. Civil Society Report on TB and COVID. The impact of COVID-19 on the TB epidemic: A community perspective. [accessed on January 27, 2021]. Available from: .
  17. 17. Shrinivasan R, Rane S, Pai M. India's syndemic of tuberculosis and COVID-19. BMJ Glob Health. 2020;5:e003979. [PMC free article] [PubMed] [Google Scholar]
  18. 18. World Health Organization. "Global tuberculosis report 2018." (2017).‏
  19. 19. World Health Organization. "Global tuberculosis report 2019." (2020).‏
  20. 20. doi: This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
  21. 21. Cilloni L, et al. The potential impact of the COVID-19pandemic on the tuberculosis epidemic a modelling analysis.EClinicalMedicine 2020; 28: 100603.
  22. 22. World Health Organization. Impact of the COVID-19pandemic on TB detection and mortality in 2020. Geneva,
  23. 23. McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG. The impact of COVID- 19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436–446. (
  24. 24. Jakubowiak WM, Bogorodskaya EW, Borisov ES, Danilova DI, Kourbatova EK. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. The International Journal of TB and Lung Disease. 2007;11(1):46–53
  25. 25. Kigozi, G., et al. "Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa." International Journal of Infectious Diseases 54 (2017): 95-102.‏
  26. 26. Slama, K., et al. "Factors associated with treatment default by tuberculosis patients in Fez, Morocco." (2013).‏
  27. 27. Raj, Yujwal, et al. "Modelling and estimation of HIV prevalence and number of people living with HIV in India, 2010–2011." International journal of STD & AIDS 27.14 (2016): 1257-1266.‏
  28. 28. Cherkaoui, Imad, et al. "Treatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility results."PloS one 9.4 (2014): e93574.‏
  29. 29. Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Ther Adv Infect Dis. 2022 May 20;9:20499361221095831. doi: 10.1177/20499361221095831.